Thrombosis and Pediatric Wegener's Granulomatosis: Acquired and Genetic Risk Factors for Hypercoagulability

Arthritis Care and Research

Volumn 49, Issue 6, 2003, Pages 862-865

  Von Scheven, Emily ^a   Lu, Theresa T ^a   Emery, Helen M ^a   Elder, Melissa E ^a   Wara, Diane W ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CYCLOPHOSPHAMIDE; ENOXAPARIN; HEPARIN; METHYLPREDNISOLONE; PREDNISONE; WARFARIN;

ADOLESCENT; ARTICLE; CLINICAL ARTICLE; CLINICAL FEATURE; DISEASE COURSE; DOSE RESPONSE; FEMALE; GENETIC RISK; HUMAN; HYPERCOAGULABILITY; MALE; PLASMAPHERESIS; RISK FACTOR; SCHOOL CHILD; THROMBOSIS; TREATMENT OUTCOME; WEGENER GRANULOMATOSIS;

EID: 0346220228     PISSN: 21514658     EISSN: None     Source Type: Journal    
DOI: 10.1002/art.11454     Document Type: Article

References (15)

1. Mickle JP, McLennan JE, Lidden CW. Cortical vein thrombosis in Wegener's granulomatosis: case report. J Neurosurg 1977;46:248-51.
2. Satoh J, Miyasaka N, Yamada T, Nishido T, Okuda M, Kuroiwa T, et al. Extensive cerebral infarction due to involvement of both anterior cerebral arteries by Wegener's granulomatosis. Ann Rheum Dis 1988;47:606-11.
3. Adlakha A, Rao K, Adlakha K, Ryu JH. A case of pediatric Wegener's granulomatosis with recurrent venous thromboses treated with intravenous immunoglobulin and laryngotracheoplasty. Pediatr Pulmonol 1995;20:265-8.
4. Hansen KE, Moore KD, Ortel TL, Allen NB. Antiphospholipid antibodies in patients with Wegener's granulomatosis and polyarteritis nodosa. Arthritis Rheum 1999;42:2250-2.
5. Meyer MF, Schnabel A, Schatz H, Gross WL. Lack of association between antiphospholipid antibodies and thrombocytopenia in patients with Wegener's granulomatosis. Semin Arthritis Rheum 2001;31:4-11.
6. Priori R, Conti F, Pittoni V, Garofalo T, Sorice M, Valesini G. Is there a role for anti-phospholipid-binding protein antibodies in the pathogenesis of thrombosis in Behcet's disease? Thromb Haemost 2000;83:173-4.
7. Wolf P, Gretler J, Aglas F, Auer-Grumbach P, Rainer F. Anticardiolipin antibodies in rheumatoid arthritis: their relation to rheumatoid nodules and cutaneous vascular manifestations. Br J Dermatol 1994;131:48-51.
8. Espinosa G, Tassies D, Font J, Munoz-Rodruigez FJ, Cervera R, Ordinas A, et al. Antiphospholipid antibodies and thrombophilic factors in Giant Cell Arteritis. Semin Arthritis Rheum 2001;31:12-20.
9. Liozon E, Roblot P, Paire D, Loustaud V, Liozon F, Vidal E, et al. Anticardiolipin antibody levels predict flares and relapses in patients with giant-cell (temporal) arteritis: a longitudinal study of 58 biopsy-proven cases. Rheumatology 2000;39:1089-94.
10. Llach F. Hypercoagulability, renal vein thrombosis, and other thrombotic complications of nephrotic syndrome. Kidney Int 1985;28:429-39.
11. De Luca M, Dugo M, Arduini R, Liessi G. Acute venous thrombosis of spleno-mesenteric portal axis: an unusual localization of thromboembolism in the nephrotic syndrome. Am J Nephrol 1991;11:260-3.
12. Thomas DP, Roberts HR. Hypercoagulability in venous and arterial thrombosis. Ann Intern Med 1997;126:638-44.
13. Noronha IL, Kruger C, Andrassy K, Ritz E, Waldherr R. In situ production of TNF-alpha, IL-1 beta and IL-2R in ANCA-positive glomerulonephritis. Kidney Int 1993;43:682-92.
14. Conway EM, Bach R, Rosenberg RD, Konigsberg WH. Tumor necrosis factor enhances expression of tissue factor mRNA in endothelial cells. Thromb Res 1989;53:231-41.
15. de Bandt M, Ollivier V, Meyer O, Babin-Chevaye C, Khechai F, de Prost D, et al. Induction of interleukin-1 and subsequent tissue factor expression by anti-proteinase 3 antibodies in human umbilical vein endothelial cells. Arthritis Rheum 1997;40:2030-8.